Posts Tagged ‘Biotech’
VR training for new Lonza employees
How to attract and retain talented workers in the Biotech Industry? And how to train the new recruits efficiently? Lonza in Visp in Switzerland created a Virtual Reality training tool. So far, 250 people were able to train with this new technology. Michael Moedler, Head of Training at Lonza. How did the project started? We were…
Read MoreInnosuisse, what changes in 2023?
As of January 2023, Innosuisse is evolving. Grants will be distributed for international projects, and the financing of start-ups will be strengthened. The revised federal law on the promotion of research and innovation (LERI) will come into effect in January 2023. Here are the main evolutions. Innovation projects Innovation projects are today financed…
Read MoreAlliance, your partner for your Innosuisse application
You have an innovative project and are thinking of submitting an Innosuisse application? With its team of specialized advisors, Alliance is your ally! Between 2020 and 2021, the EPFL based association has raised over CHF 57 million for Swiss SMEs. What is Alliance and how was the structure created? Alliance is the technological innovation…
Read MoreGeNeuro starts a clinical trials for its long COVID treatment
200 patients are recruited and will be followed in 5 Swiss hospitals participating in the study. The first results are expected during the second semester 2023. GeNeuro is a biopharmaceutical company developing new treatments for neurodegenerative and autoimmune diseases such as multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS) and the severe consequences of…
Read MoreEUR 3.7 million for ONWARD and its partners from the European Innovation Council (EIC)
The European Innovation Council Grant has been awarded to ONWARD and its research partners, including EPFL, IICT-BAS, CEA-Leti-Clinatec, and CEAList. The company also received the First Place Winner of the 2022 Brain-Computer Interface (BCI) Award. ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative therapies to restore movement, independence, and health in…
Read MoreProf. Jocelyne Bloch and Prof. Grégoire Courtine receive the BioAlps Academia Award, and Incyte the BioAlps Industry Award
The ceremony closed the BioAlps Networking Day on 24 November 2022 in Neuchâtel, in front of 250 key players of the Health Valley Region. BioAlps Academia Award 2022 As a teenager, Grégoire Courtine was a Superman fan. The hero was played at the time by Christopher Reeves. A riding accident left the famous actor…
Read MoreObsEva Announces Sale of Ebopiprant License Agreement to XOMA for up to $113 Million
The Swiss company expects the sale proceeds to resolve its current over-indebtedness position ObsEva SA, a biopharmaceutical company based in Geneva Switzerland, developing novel therapies for women’s health, today announced the sale of all of the Company’s rights to Ebopiprant to XOMA Corporation (XOMA) for an upfront payment of $15 million and future milestone payments…
Read MoreOpna Bio Raises $38M in Series A Financing
Opna Bio, an Epalinges, Switzerland and San Francisco, CA-based clinical-stage biopharmaceutical company, raised $38M in Series A funding. The round was led by Longitude Capital and Northpond Ventures, with participation from Menlo Ventures. The proceeds will be used to develop novel fragile-X mental retardation protein (FMRP) inhibitors in oncology as well as a diverse…
Read MoreNovigenix announces first closing of its $20M Series B
The company validated its approach in Colorectal Cancer (CRC) screening, and provides new molecular insights and predictive algorithms for patient stratification and monitoring of Immunotherapies. Novigenix SA, a leading data-driven precision medicine biotech based in Biopôle Lausanne, that develops and commercializes Immuno-Transcriptomic precision oncology solutions, today announced a successful first closing of its $20…
Read MoreMICROCITY Neuchâtel, Land of Diagnostic
A Human lean Diagnostic programme in the canton of precision watchmaking The historical heritage of high precision and core competencies in micro and nanotechnologies (micromechanics, microelectronics, advanced manufacturing) as well as its unique expertise in miniaturization, ultra-low energy consumption, reliability and complexity mean that the canton of Neuchâtel can connect all the competencies necessary…
Read More